The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EKSO | -60.56% | -93.49% | -42.07% | -100% |
| S&P | +13.19% | +87.83% | +13.42% | +265% |
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $4.23M | 2.4% |
| Gross Profit | $2.55M | 15.4% |
| Gross Margin | 60.30% | 6.8% |
| Market Cap | $13.40M | -47.5% |
| Market Cap / Employee | $0.22M | 0.0% |
| Employees | 61 | -12.9% |
| Net Income | -$1.42M | 31.4% |
| EBITDA | -$1.04M | 53.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.72M | -67.2% |
| Accounts Receivable | $6.05M | -13.2% |
| Inventory | 5 | -0.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.31M | -72.0% |
| Short Term Debt | $3.65M | 116.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -41.02% | -4.2% |
| Return On Invested Capital | -85.87% | 17.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2.07M | 9.3% |
| Operating Free Cash Flow | -$2.06M | 9.5% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.07 | 0.90 | 0.49 | 1.22 | -28.75% |
| Price to Sales | 0.84 | 0.58 | 0.49 | 0.91 | -31.71% |
| Price to Tangible Book Value | 20.59 | 17.44 | 0.78 | 2.13 | -94.55% |
| Enterprise Value to EBITDA | -7.93 | -2.55 | -2.03 | -15.12 | 56.18% |
| Return on Equity | -89.5% | -80.7% | -96.4% | -85.0% | 15.04% |
| Total Debt | $5.98M | $5.62M | $5.39M | $4.96M | -21.92% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
